Rodríguez CNM, Medina RM, Flores GR, Robles AJ

Language: Spanish
References: 18
Page: 172-175
PDF size: 201.42 Kb.

ABSTRACT

Objective. To evaluate the analgesic respons to bolus nalbuphine or intravenous infusion. Material and methods. Longitudinal, prospective, experimental and comparative study, including 12 patients with presumably acute pain, 7 posoperative patients and 5 with multiple trauma injuries either treated with bolus or infusion nalbuphine. We recorder the OUCHER, CHEOPS, 9 faces interval, analogue visual scales and physiological dates for periods of 4 hour. Statistical analysis by means of central tendency, the coefficient of correlation and Spearman correlations. Results. The results are presented as the mean and SD. The level of statistical significance was set at p ‹ 0.05. To both groups the physiological was found at p › 0.05 also OUCHER and CHEOPS. The coefficient of correlation for cardiac and respiratory rate (CR and RR) bolus nalbuphine was CR = 0.31- 0.50, RR = 0.22 - 0.54. The CHEOPS had a correlation Spearman rs = + 0.23 with bolus nalbuphine and infusion rs = 0.50 (p › 0.05). To OUCHER with bolus, rs = -0.25 an infusion rs = 0.27(p ‹ 0.05). The E and D faces had a correlation with bolus nalbuphine (50-70%). Conclusions. We did not found an statistical significance between physiological datas, CHEOPS and OUCHER whit nalbuphine either bolus or infusion. Further investigation are required to determine analgesic respons and appropriate treatment on children population.

REFERENCES

1. Aristóteles. Treatise on the principles of life. NA Hanmmond libro 2; cap 6; libro 3, cap 1, 1902.

2. Schechter NL. Tratamiento insuficiente del dolor en el niño. Pediatr Clin North Am 1989; 36: 845-57.

3. McGrath PJ, Crais KD. Factores del desarrollo psicológico del dolor en niños. Pediatr Clin North Am 1989; 36: 893-905.

4. Sacchetti A, Schafermeyer R et al. Pediatric analgesia and sedation. Ann Emerg Med 1994; 23: 237-50.

5. Leonard R, Roy M. Emergency Department Analgesic. Use in pediatric trauma victims with fractures. Ann Emerg Med 1994; 23: 203-207.

6. Beyer JE, Wells N. Valoración del dolor en niños. Pediatr Clin North Am 1989; 36: 909-92.

7. Terregrosa Z, Bugedo T. Medición del dolor. Bol Esc Med Univ Católica Chile 1994; 23: 155-58.

8. González A, Concha P. Dolor agudo en niños. Bol Esc Med Univ Católica Chile 1994; 23: 174-176.

9. Paeille J, Hernán S. Métodos que miden las cualidades del dolor. El dolor, aspectos básicos y clínicos. Santiago de Chile: Ed. Mediterráneo l988.

10. Ruza. Sedación y analgesia en el niño. Tratado de cuidados intensivos pediátricos, 2a edición, Madrid España: Ediciones Norma 1994; 84.91.

11. Anand KJ, Carr DB. Neuroanatomía, neurofisiología y neuroquímica del dolor en neonatos y niños. Pediatr Clin North Amer 1989; 36: 861-883.

12. Doenicke A, Moss J et al. Intravenous morphine an nalbuphine increages. Clin Pharmacol Ther 1995; 58: 81-9.

13. Errol B, William K et al. Nalbuphine. An autoradiographic opioid receptor binding profile in the central nervous system of an agonist/antagonist analgesic. J Pharmacol Exp Ther 1988; 244: 391-402.

14. White P. Clinical uses of intravenous anesthetic and analgesic infusions. Anesth Analg 1989; 68: 161-71.

15. Ellen A, Walker et al. Discriminative-stimulus effects of the efficacy Mu agonist nalbuphine. J Pharmacol Exp Ther 1993; 286: 322-30.

16. Chaim G, Dennis P. Nalbuphine, a mixed Kappa an kappa 3 analgesic in mice. J Pharmacol Exp Ther 1992; 262: 1044-50.

17. Gómez J, Puon A. Estudio comparativo entre brupenorfina, fentanyl y nalbufina en el periodo perioperatorio de cirugía de cadera. Anest Mex 1996; 2: 82-87.

18. INP. Criterios pediátricos. Uso de nalbufina. México: Instituto Nacional de Pediatría 1992.